Correlation Between Isofol Medical and Dignitana

Can any of the company-specific risk be diversified away by investing in both Isofol Medical and Dignitana at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Isofol Medical and Dignitana into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Isofol Medical AB and Dignitana AB, you can compare the effects of market volatilities on Isofol Medical and Dignitana and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Isofol Medical with a short position of Dignitana. Check out your portfolio center. Please also check ongoing floating volatility patterns of Isofol Medical and Dignitana.

Diversification Opportunities for Isofol Medical and Dignitana

-0.02

Correlation Coefficient

Isofol Medical  Dignitana

Good diversification

The 3 months correlation between Isofol and Dignitana is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Isofol Medical AB and Dignitana AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dignitana AB and Isofol Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Isofol Medical AB are associated (or correlated) with Dignitana. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dignitana AB has no effect on the direction of Isofol Medical i.e., Isofol Medical and Dignitana go up and down completely randomly.

Pair Corralation between Isofol Medical and Dignitana

Assuming the 90 days trading horizon Isofol Medical AB is expected to under-perform the Dignitana. But the stock apears to be less risky and, when comparing its historical volatility, Isofol Medical AB is 1.97 times less risky than Dignitana. The stock trades about -0.01 of its potential returns per unit of risk. The Dignitana AB is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  94.00  in Dignitana AB on December 27, 2024 and sell it today you would earn a total of  114.00  from holding Dignitana AB or generate 121.28% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Isofol Medical AB  vs.  Dignitana AB

Isofol Medical AB

Risk-Adjusted Performance

Very Weak

Over the last 90 days Isofol Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Isofol Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Dignitana AB

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Dignitana AB are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Dignitana unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Isofol Medical and Dignitana

The main advantage of trading using opposite Isofol Medical and Dignitana positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Isofol Medical position performs unexpectedly, Dignitana can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dignitana will offset losses from the drop in Dignitana's long position.

The idea behind Isofol Medical AB and Dignitana AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.